News on government policy and legislation impacting life science and diagnostics.
Both sides have filed competing arguments requesting the judge rule on the case without a trial.
The lab industry's appeal to CMS follows Missouri's Medicaid agency's reduction of lab reimbursements from 100 percent to 80 percent of Medicare rates.
These lobbying efforts aim to shore up willingness among legislators to step in and halt implementation of the NCD if certain provisions remain in the final version.
At the ACLA conference this week, FDA Commissioner Gottlieb outlined his vision for the agency in the realm of LDTs.
The new recommendation is a positive for Qiagen and Oxford Immunotec, both of which market interferon gamma-release assays.